December 15, 2009 - The European Medicines Agency (EMEA) recently approved a new indication for Procoralan (ivabradine) for chronic, stable angina patients, who remain inadequately controlled despite an optimal dose of beta blockers, and whose heart rate is above 60 beats per minute.

December 14, 2009 – A new drug application (NDA) was recently submitted to the U.S. Food and Drug Administration (FDA) for ticagrelor, an investigational oral anti-platelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndrome (ACS).

December, 14, 2009 – A supplemental new drug application (sNDA) has been submitted to the U.S. Food and Drug Administration (FDA) for two new dosage strengths of SIMCOR, a cholesterol medication.

December 14, 2009 – First new anti-arrhythmic drug to be approved in the European Union in the last 10 years was recently granted European Commission marketing authorization.

December 14, 2009 – For its unique Return to Work Lab, which focuses on individualized rehabilitation for younger, more active cardiac patients, the Baylor Jack and Jane Hamilton Heart and Vascular Hospital in north Texas recently received an award.

December 11, 2009 – At this year’s Radiology Society of America (RSNA) annual meeting last week, GE Healthcare, presented the new Innova dose-efficient X-ray technology to reduce patient radiation exposure.

December 11, 2009 – A new nonlinear algorithm has been selected for a month-long April 2010 noninvasive cardiac screening of teenagers in danger of sudden cardiac death in south east London. Vicor Technologies Inc. said its PD2i nonlinear algorithm will be used along with ECG and echocardiogram to identify those at risk.

December 10, 2009 – European approval was recently granted for the use of Angiox (bivalirudin) as an anti-coagulant in patients with ST-segment elevated myocardial infarction (STEMI) who undergoing emergency primary percutaneous coronary intervention (PCI).

December 10, 2009 – An exclusive license agreement between On-X Life Technologies and the Cleveland Clinic will create a system of products intended to improve and simplify the replacement of damaged or severed mitral valve chordae. The system is the creation of co-inventors A. Marc Gillinov, M.D., a staff cardiac surgeon at Cleveland Clinic, and Michael K.

December 9, 2009 β€” A new cardiovascular care system was previewed during the recent Medica exhibition in Germany. The system, slated for a 2010 launch, provides clinical decision support for cardiovascular care of critically ill patients.

Subscribe to
Β© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now